최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, v.130, 2018년, pp.143 - 151
Ho, Myoung Jin (College of Pharmacy, Dankook University) , Lee, Dae Ro (College of Pharmacy, Dankook University) , Im, Sung Hyun (College of Pharmacy, Dankook University) , Yoon, Jeong A (College of Pharmacy, Dankook University) , Shin, Chang Yong (Dong-A Pharmaceutical Co. Ltd.) , Kim, Hyun Jung (Dong-A Pharmaceutical Co. Ltd.) , Jang, Sun Woo (Dong-A Pharmaceutical Co. Ltd.) , Choi, Young Wook (College of Pharmacy, Chung-Ang University) , Han, Young Taek (College of Pharmacy, Dankook University) , Kang, Myung Joo (College of Pharmacy, Dankook University)
Abstract The objectives of this study were to formulate microcrystals of entecavir-3-palmiate (EV-P), a palmitic acid ester of entecavir (EV), and evaluate the influence of particle size on its pharmacokinetic behavior following subcutaneous (SC) injection. Systemic toxicity and local tolerability ...
Mol. Pharm. Remenar 11 1739 2014 10.1021/mp500070m Making the leap from daily oral dosing to long-acting injectables: lessons from the antipsychotics
Eur. J. Pharm. Biopharm. Goke 2017 Novel strategies for the formulation and processing of poorly water-soluble drugs
Int. J. Nanomed. Junghann 3 295 2008 Nanocrystal technology, drug delivery and clinical applications
Int. J. Pharm. Van Eerdenbrugh 364 64 2008 10.1016/j.ijpharm.2008.07.023 Topdown production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products
Clin. Pharmacokinet. Samtani 48 585 2009 10.2165/11316870-000000000-00000 Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia
Schizophr. Res. Turncliff 159 404 2014 10.1016/j.schres.2014.09.021 Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia
Eur. J. Pharm. Biopharm. Mittapelly 101 62 2016 10.1016/j.ejpb.2016.01.003 Investigation of salt formation between memantine and pamoic acid: Its exploitation in nanocrystalline form as long acting injection
J. Pharm. Sci. Liederer 95 1177 2006 10.1002/jps.20542 Enzymes involved in the bioconversion of ester-based prodrugs
Clin. Ther. Matthews 28 184 2006 10.1016/j.clinthera.2006.02.012 Entecavir for the treatment of chronic hepatitis B virus infection
Hepatology Lok 50 661 2009 10.1002/hep.23190 Chronic hepatitis B: update 2009
Hepatology Chang 52 886 2010 10.1002/hep.23785 Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
Entecavir pharmacology review. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/21797_21798_BaracludeTOC.cfm.
Int. J. Pharm. Ho 543 52 2018 10.1016/j.ijpharm.2018.03.042 Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery
Pharm. World Sci. Kadir 15 173 1993 10.1007/BF01880562 Intramuscular and subcutaneous drug delivery: encapsulation in liposomes and other methods to manipulate drug availability
Adv. Drug Deliv. Rev. Medlicott 56 1345 2004 10.1016/j.addr.2004.02.005 Sustained release veterinary parenteral products
Int. J. Pharm. Zuidema 105 189 1994 10.1016/0378-5173(94)90103-1 Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II)
Pharm. Res. Champion 25 1815 2008 10.1007/s11095-008-9562-y Role of particle size in phagocytosis of polymeric microspheres
PLoS One Kusaka 9 e92634 2014 10.1371/journal.pone.0092634 Effect of silica particle size on macrophage inflammatory responses
J. Control. Release Darville 230 95 2016 10.1016/j.jconrel.2016.03.041 The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension
Semin. Immunol. Anderson 20 86 2008 10.1016/j.smim.2007.11.004 Foreign body reaction to biomaterials
Haddad 2011 Antipsychotic Long-acting Injections
Invega Sustenna® pharmacological review; 2010. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022264s000pharmr.pdf.
Drug Deliv. Zhao 21 467 2014 10.3109/10717544.2014.881438 Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation
J. Biomed. Nanotechnol. Kuntsche 5 384 2009 10.1166/jbn.2009.1047 Size determinations of colloidal fat emulsions: a comparative study
Langmuir Matteucci 22 8951 2006 10.1021/la061122t Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization
J.W. Kostanski, T. Matsuda, M. Nerurkar, V.H. Naringrekar, Controlled release sterile injectable aripiprazole formulation and method, 2007, US8030313.
Spine J. Tiso 4 468 2004 10.1016/j.spinee.2003.10.007 Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids
G. Malhotra, S. Singh, K.A. Ansari, Paliperidone palmitate particles and compositions thereof, 2016, WO2016199170.
Pharm. Res. Paquette 31 2065 2014 10.1007/s11095-014-1308-4 Long-acting atypical antipsychotics: characterization of the local tissue response
Arch. Histol. Cytol. Kawamata 66 273 2003 10.1679/aohc.66.273 Structure of the rat subcutaneous connective tissue in relation to its sliding mechanism
Expert Opin. Drug Deliv. Frost 4 427 2007 10.1517/17425247.4.4.427 Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Curr. Opin. Mol. Ther. McDonald 12 461 2010 Subcutaneous administration of biotherapeutics: current experience in animal models
Comp. Biochem. Physiol. A Rendell 106 349 1993 10.1016/0300-9629(93)90524-8 Skin blood flow in the wistar-kyoto rat and the spontaneously hypertensive rat
Xenobiotica Moss 45 60 2015 10.3109/00498254.2014.942409 The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys
J. Pharm. Sci. Darville 103 2072 2014 10.1002/jps.24014 Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats
Center for Drug Evaluation and Research (CDER), Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers, 2005.
Invega sustenna® product information, 2010. Available at: http://www.janssen.com/australia/sites/www_janssen_com_australia/files/prod_files/live/invega_sustenna_pi.pdf.
Drug Res. Huang 63 644 2013 10.1055/s-0033-1358665 A validated method for quantifying entecavir in biological matrices and its application in a pharmacokinetic study in rats and dogs
Eur. J. Pharm. Biopharm. Baert 72 502 2009 10.1016/j.ejpb.2009.03.006 Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
Toxicol. Pathol. Darville 44 189 2015 10.1177/0192623315618291 Modeling the time course of the tissue responses to intramuscular long acting paliperidone palmitate nano-/microcrystals and polystyrene microspheres in the rat
Biophys. J. Simon 53 163 1988 10.1016/S0006-3495(88)83078-9 Biophysical aspects of microsphere engulfment by human-neutrophils
European Medicines Agency assessment report of Baraclude® tablet, 2014. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000623/human_med_000670.jsp&mid=WC0b01ac058001d124.
Lancet Margolis 390 1499 2017 10.1016/S0140-6736(17)31917-7 Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.